Abeona Therapeutics Inc. (LON:0H7R)
5.99
-0.20 (-3.22%)
At close: Jun 16, 2025
Abeona Therapeutics Employees
Abeona Therapeutics had 136 employees as of December 31, 2024. The number of employees increased by 52 or 61.90% compared to the previous year.
Employees
136
Change (1Y)
52
Growth (1Y)
61.90%
Revenue / Employee
n/a
Profits / Employee
-251.46K GBP
Market Cap
227.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Indivior | 1,051 |
Abeona Therapeutics News
- 14 days ago - Abeona Therapeutics: Substantially Undervalued Post-FDA Approval (Rating Upgrade) - Seeking Alpha
- 16 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Abeona Therapeutics® to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Abeona targets treating 10–14 ZEVASKYN patients in 2025 while securing $155M PRV sale to extend runway - Seeking Alpha
- 4 weeks ago - Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Abeona Therapeutics GAAP EPS of -$0.24 beats by $0.12 - Seeking Alpha
- 4 weeks ago - Abeona Therapeutics® Reports First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 5 weeks ago - UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder - GlobeNewsWire